TickerStat.com

BlossomHill Therapeutics, Inc. (BLSM)

Price—Loading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Research & development$56.1M$31.8M
Operating income−$64.0M−$36.4M
Net income−$60.6M−$30.7M
Diluted EPSper diluted share-$24.83-$13.40
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗